Market Overview:
The global polymerase chain reaction (PCR) market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth in the PCR market can be attributed to the increasing demand for molecular diagnostics and rising prevalence of infectious diseases. Additionally, technological advancements in PCR are also contributing to the growth of this market. The traditional PCR segment is expected to dominate the global PCR market during the forecast period owing to its low cost and high accuracy. However, real-time PCR is projected to grow at a higher CAGR during the forecast period as it offers faster results with increased accuracy. On the basis of application, diagnostic centers & hospitals accounted for majority share of revenue in 2017 and this trend is anticipated continue throughout the forecast period. This can be attributed rise in number of infectious diseases across globe and growing demand for molecular diagnostics tests.
Product Definition:
A polymerase chain reaction (PCR) is a laboratory technique used to amplify a single piece of DNA by generating many copies of it. PCR is commonly used in research and diagnostic laboratories to amplify segments of DNA from clinical samples, such as blood or tissue. The polymerase chain reaction was first described in 1983 by Kary Mullis, who was awarded the Nobel Prize in Chemistry for his work on the technique.
Real-Time PCR:
Real-time PCR (qPCR) is a technique that helps in detecting and quantifying nucleic acid sequences at an extremely high speed. It involves the use of a DNA amplification process to produce multiple copies of DNA, which are then detected and quantified using various detection techniques. The technology has been used for decades; however, it has only recently gained widespread acceptance due to its accuracy, sensitivity & specificity as well as cost effectiveness.
Traditional PCR:
Traditional PCR (polymerase chain reaction) is a method of genetic testing that uses DNA as a probe to amplify millions of times. It is the most common and well-known type of PCR technology. The process works by replicating specific sections of DNA over and over again, creating many copies of the target sequence. This process is then used to detect, identify, quantify or purify nucleic acids (DNA & RNA).
Application Insights:
The others application segment includes food and beverage, environmental testing, clinical testing centers and hospitals, pharmaceutical companies, research institutes/universities. The PCR technique is widely used in the detection of microorganisms including bacteria and viruses due to its ability to amplify a target DNA sequence with high specificity and sensitivity. This technique helps detect very low quantities of targets which were not possible before the introduction of PCR technology.
The diagnostic centers & hospitals application segment accounted for the largest revenue share in 2017 owing to an increase in demand for rapid diagnosis of diseases such as H1N1 influenza A&B virus among patients at emergency rooms along with other infectious diseases that require rapid test kits. Furthermore, an increase in investment by governments across various countries towards establishing advanced healthcare facilities is expected to boost market growth over the forecast period. Increasing investments by pharmaceutical companies towards R&D activities related to cancer diagnostics & treatment is also projected to drive industry growth over the coming years.
Regional Analysis:
North America dominated the global market in 2017. The presence of sophisticated healthcare infrastructure, high adoption rate of advanced technologies, and increasing focus on R&D activities are some factors responsible for North America’s dominance. Asia Pacific is expected to be the fastest-growing regional market during the forecast period owing to rising penetration of digital PCR systems and improving healthcare infrastructure in emerging countries such as China and India. Moreover, an increase in disease prevalence levels coupled with growing awareness about early diagnosis will drive demand further.
Growth Factors:
- Increasing demand for nucleic acid testing in clinical diagnostics
- Rising prevalence of infectious diseases
- Technological advancements in PCR instruments and assays
- Growing application of PCR in personalized medicine and research studies
- Increasing funding for molecular biology research
Scope Of The Report
Report Attributes
Report Details
Report Title
Polymerase Chain Reaction Market Research Report
By Type
Real-Time PCR, Traditional PCR, Digital PCR
By Application
Diagnostic Centers & Hospitals, Academic & Research Institutions, Others
By Companies
Bio-Rad Laboratories, QIAGEN, F. Hoffmann-La Roche, Thermo Fisher Scientific, bioMérieux
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
166
Number of Tables & Figures
117
Customization Available
Yes, the report can be customized as per your need.
Global Polymerase Chain Reaction Market Report Segments:
The global Polymerase Chain Reaction market is segmented on the basis of:
Types
Real-Time PCR, Traditional PCR, Digital PCR
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Diagnostic Centers & Hospitals, Academic & Research Institutions, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bio-Rad Laboratories
- QIAGEN
- F. Hoffmann-La Roche
- Thermo Fisher Scientific
- bioMérieux
Highlights of The Polymerase Chain Reaction Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Real-Time PCR
- Traditional PCR
- Digital PCR
- By Application:
- Diagnostic Centers & Hospitals
- Academic & Research Institutions
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Polymerase Chain Reaction Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Polymerase Chain Reaction (PCR) is a technique used to amplify specific DNA sequences. PCR is often used to determine the sequence of a gene or to identify the presence of a particular gene in an organism.
Some of the major players in the polymerase chain reaction market are Bio-Rad Laboratories, QIAGEN, F. Hoffmann-La Roche, Thermo Fisher Scientific, bioMƒÂ©rieux.
The polymerase chain reaction market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Polymerase Chain Reaction Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Polymerase Chain Reaction Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Polymerase Chain Reaction Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Polymerase Chain Reaction Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Polymerase Chain Reaction Market Size & Forecast, 2018-2028
4.5.1 Polymerase Chain Reaction Market Size and Y-o-Y Growth
4.5.2 Polymerase Chain Reaction Market Absolute $ Opportunity
Chapter 5 Global Polymerase Chain Reaction Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Polymerase Chain Reaction Market Size Forecast by Type
5.2.1 Real-Time PCR
5.2.2 Traditional PCR
5.2.3 Digital PCR
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Polymerase Chain Reaction Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Polymerase Chain Reaction Market Size Forecast by Applications
6.2.1 Diagnostic Centers & Hospitals
6.2.2 Academic & Research Institutions
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Polymerase Chain Reaction Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Polymerase Chain Reaction Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Polymerase Chain Reaction Analysis and Forecast
9.1 Introduction
9.2 North America Polymerase Chain Reaction Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Polymerase Chain Reaction Market Size Forecast by Type
9.6.1 Real-Time PCR
9.6.2 Traditional PCR
9.6.3 Digital PCR
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Polymerase Chain Reaction Market Size Forecast by Applications
9.10.1 Diagnostic Centers & Hospitals
9.10.2 Academic & Research Institutions
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Polymerase Chain Reaction Analysis and Forecast
10.1 Introduction
10.2 Europe Polymerase Chain Reaction Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Polymerase Chain Reaction Market Size Forecast by Type
10.6.1 Real-Time PCR
10.6.2 Traditional PCR
10.6.3 Digital PCR
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Polymerase Chain Reaction Market Size Forecast by Applications
10.10.1 Diagnostic Centers & Hospitals
10.10.2 Academic & Research Institutions
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Polymerase Chain Reaction Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Polymerase Chain Reaction Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Polymerase Chain Reaction Market Size Forecast by Type
11.6.1 Real-Time PCR
11.6.2 Traditional PCR
11.6.3 Digital PCR
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Polymerase Chain Reaction Market Size Forecast by Applications
11.10.1 Diagnostic Centers & Hospitals
11.10.2 Academic & Research Institutions
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Polymerase Chain Reaction Analysis and Forecast
12.1 Introduction
12.2 Latin America Polymerase Chain Reaction Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Polymerase Chain Reaction Market Size Forecast by Type
12.6.1 Real-Time PCR
12.6.2 Traditional PCR
12.6.3 Digital PCR
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Polymerase Chain Reaction Market Size Forecast by Applications
12.10.1 Diagnostic Centers & Hospitals
12.10.2 Academic & Research Institutions
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Polymerase Chain Reaction Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Polymerase Chain Reaction Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Polymerase Chain Reaction Market Size Forecast by Type
13.6.1 Real-Time PCR
13.6.2 Traditional PCR
13.6.3 Digital PCR
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Polymerase Chain Reaction Market Size Forecast by Applications
13.10.1 Diagnostic Centers & Hospitals
13.10.2 Academic & Research Institutions
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Polymerase Chain Reaction Market: Competitive Dashboard
14.2 Global Polymerase Chain Reaction Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bio-Rad Laboratories
14.3.2 QIAGEN
14.3.3 F. Hoffmann-La Roche
14.3.4 Thermo Fisher Scientific
14.3.5 bioMérieux
